| Date Filed | Type | Description |
| 12/16/2022 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Paid exercise price by delivering 2,320 shares
@ $17.23, valued at
$40k
Exercised 6,966 restricted stock units
@ $0 |
|
| 09/28/2022 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Paid exercise price by delivering 2,180 shares
@ $18.87, valued at
$41.1k
Exercised 6,546 restricted stock units
@ $0 |
|
| 07/08/2022 |
4
| Erck Stanley C (Director) has filed a Form 4 on MAXCYTE, INC.|
Txns:
| Granted 26,900 options to buy
@ $4.82, valued at
$129.7k
|
|
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2021 |
4
| Erck Stanley C (Director) has filed a Form 4 on MAXCYTE, INC.|
Txns:
| Granted 10,000 options to buy
@ $16.63, valued at
$166.3k
|
|
| 07/29/2021 |
3
| Erck Stanley C (Director) has filed a Form 3 on MAXCYTE, INC. |
| 07/06/2021 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Sold 2,046 shares
@ $209.2027, valued at
$428k
Sold 6,105 shares
@ $210.0229, valued at
$1.3M
Sold 4,117 shares
@ $211.0679, valued at
$869k
Sold 6,419 shares
@ $212.1527, valued at
$1.4M
Sold 12,703 shares
@ $213.071, valued at
$2.7M
Sold 12,917 shares
@ $214.127, valued at
$2.8M
Sold 6,984 shares
@ $214.9681, valued at
$1.5M
Sold 1,329 shares
@ $215.6983, valued at
$286.7k
Sold 1,970 shares
@ $210.2299, valued at
$414.2k
Sold 4,242 shares
@ $211.2084, valued at
$895.9k
Sold 7,616 shares
@ $212.2878, valued at
$1.6M
|
|
| 12/16/2020 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 41,700 options to buy
@ $129.7, valued at
$5.4M
Granted 20,900 restricted stock units
@ $0 |
|
| 11/18/2020 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Sold 5,766 shares
@ $87.2042, valued at
$502.8k
Sold 8,306 shares
@ $88.36, valued at
$733.9k
Sold 11,234 shares
@ $89.2566, valued at
$1M
Sold 4,598 shares
@ $90.6128, valued at
$416.6k
Sold 17,503 shares
@ $92.9721, valued at
$1.6M
Sold 4,909 shares
@ $93.5613, valued at
$459.3k
Exercised 42,499 options to buy
@ $39.8, valued at
$1.7M
Exercised 9,818 options to buy
@ $25.6, valued at
$251.3k
|
|
| 10/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2019 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 100,000 options to buy
@ $5.95, valued at
$595k
Granted 100,000 rights
@ $5.95, valued at
$595k
Granted 19,638 restricted stock units
@ $0 |
|
| 03/12/2019 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 607,248 restricted stock units
@ $0 |
|
| 12/14/2018 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 1,970,000 options to buy
@ $2.3, valued at
$4.5M
|
|
| 11/30/2018 |
4
| Erck Stanley C (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Exercised 8,333 options to buy
@ $1.49, valued at
$12.4k
|
|
| 06/22/2018 |
4
| Erck Stanley C (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $6.09, valued at
$182.7k
|
|
| 05/15/2018 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Bought 100,000 shares
@ $1.6462, valued at
$164.6k
|
|
| 12/19/2017 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 1,650,000 options to buy
@ $1.38, valued at
$2.3M
|
|
| 11/13/2017 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Bought 100,000 shares
@ $1.1305, valued at
$113.1k
|
|
| 05/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/01/2016 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Sold 198,009 shares
@ $5.1917, valued at
$1M
Sold 226,769 shares
@ $5.1842, valued at
$1.2M
Exercised 198,009 options to buy
@ $1.28, valued at
$253.5k
Exercised 201,991 options to buy
@ $1.28, valued at
$258.5k
|
|
| 06/03/2013 |
4
| Erck Stanley C (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $1.71, valued at
$25.7k
|
|
| 03/06/2013 |
4
| Erck Stanley C (President and CEO) has filed a Form 4 on NOVAVAX INC|
Txns:
| Granted 900,000 options to buy
@ $1.83, valued at
$1.6M
|
|
|